Harmony Biosciences Holdings, Inc.
HRMY
$38.12
-$0.38-0.99%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 30.32% | 16.59% | 21.12% | 28.71% | 16.01% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 30.32% | 16.59% | 21.12% | 28.71% | 16.01% |
| Cost of Revenue | 65.64% | 39.13% | 25.98% | 39.44% | 18.69% |
| Gross Profit | 22.02% | 11.87% | 19.32% | 25.51% | 15.40% |
| SG&A Expenses | -2.85% | 3.63% | 53.62% | 5.69% | 14.83% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 12.90% | 38.61% | 41.01% | 39.93% | 0.56% |
| Operating Income | 85.38% | -33.70% | -30.81% | 6.12% | 125.60% |
| Income Before Tax | 87.89% | -30.59% | -27.42% | 8.56% | 128.81% |
| Income Tax Expenses | 80.85% | -38.03% | 173.56% | 3.41% | -2.40% |
| Earnings from Continuing Operations | 89.64% | -28.69% | -54.55% | 10.35% | 243.16% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 89.64% | -28.69% | -54.55% | 10.35% | 243.16% |
| EBIT | 85.38% | -33.70% | -30.81% | 6.12% | 125.60% |
| EBITDA | 75.97% | -30.47% | -25.46% | 5.58% | 97.56% |
| EPS Basic | 88.12% | -29.32% | -54.98% | 9.04% | 239.10% |
| Normalized Basic EPS | 86.40% | -31.21% | -28.10% | 7.27% | 126.14% |
| EPS Diluted | 88.24% | -29.49% | -55.05% | 10.13% | 240.00% |
| Normalized Diluted EPS | 86.84% | -30.89% | -28.01% | 7.43% | 125.38% |
| Average Basic Shares Outstanding | 0.81% | 0.89% | 0.94% | 1.20% | 1.17% |
| Average Diluted Shares Outstanding | 0.56% | 0.43% | 0.82% | 1.06% | 1.54% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |